Stock market week-in-review for 5 large GI companies — Oct. 2-6

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Oct. 2 to Oct. 6, 2017.

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $204.89 on Oct. 2
Peaked: $213.88 on Oct. 3
Closed: $206.68 Oct. 6
Percent change between Oct. 2 and Oct. 6: 0.87 percent

2. Exact Sciences Corp.

Opened: $46.76 on Oct. 2
Peaked: $50.46 on Oct. 3
Closed: $48.63 on Oct. 6
Percent change between Oct. 2 and Oct. 6: 3.99 percent

3. Johnson & Johnson

Opened: $130.25 on Oct. 2
Peaked: $133.26 on Oct. 5
Closed: $133.17 on Oct. 6
Percent change between Oct. 2 and Oct. 6: 2.24 percent

4. Synergy Pharmaceuticals

Opened: $2.90 on Oct. 2
Peaked: $3.53 on Oct. 5
Closed: $3.46 on Oct. 6
Percent change between Oct. 2 and Oct. 6: 19.31 percent

5. Valeant Pharmaceuticals

Opened: $14.33 on Oct. 2
Peaked: $14.74 on Oct. 3
Closed: $14.46 on Oct. 6
Percent change between Oct. 2 and Oct. 6: 0.90 percent

More articles on gastroenterology: 
Medicare saved $8.8M by shifting colonoscopies to Tennessee ASCs: 3 quick facts
GI leader to know: Dr. Rand Compton of Centers for Gastroenterology
Takeda donates $100k to local nonprofits — 4 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months